Home

AMN Healthcare Services Inc (AMN)

17.88
-0.55 (-2.98%)
NYSE · Last Trade: Nov 7th, 10:49 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close18.43
Open19.48
Bid17.77
Ask17.88
Day's Range16.73 - 19.82
52 Week Range14.87 - 42.41
Volume1,077,001
Market Cap845.05M
PE Ratio (TTM)-2.298
EPS (TTM)-7.8
Dividend & YieldN/A (N/A)
1 Month Average Volume732,187

Chart

About AMN Healthcare Services Inc (AMN)

AMN Healthcare Services Inc is a leading provider of workforce solutions and staffing services in the healthcare sector. The company specializes in connecting healthcare facilities with qualified professionals, including nurses and physicians, to address temporary and permanent staffing needs. With a focus on delivering high-quality care, AMN offers a range of services that include talent acquisition, workforce management, and consulting solutions. By leveraging technology and data analytics, they assist healthcare organizations in optimizing their workforce and improving patient outcomes. AMN is committed to enhancing the healthcare experience by ensuring that facilities have the necessary personnel to meet the demands of patient care. Read More

News & Press Releases

AMN Q3 Deep Dive: Labor Disruption Activity and Staffing Mix Drive Guidance Upside
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 7.7% year on year to $634.5 million. On top of that, next quarter’s revenue guidance ($722.5 million at the midpoint) was surprisingly good and 16.4% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 95.2% above analysts’ consensus estimates.
Via StockStory · November 7, 2025
AMN Healthcare Services Inc (NYSE:AMN) Surpasses Q3 Estimates and Provides Strong Q4 Outlookchartmill.com
AMN Healthcare (AMN) stock rose after Q3 earnings beat estimates and the company issued strong Q4 revenue guidance, signaling a positive outlook.
Via Chartmill · November 6, 2025
AMN Healthcare Services’s (NYSE:AMN) Q3 Sales Top Estimates, Stock Soars
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 7.7% year on year to $634.5 million. On top of that, next quarter’s revenue guidance ($722.5 million at the midpoint) was surprisingly good and 16.4% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 95.2% above analysts’ consensus estimates.
Via StockStory · November 6, 2025
Earnings Scheduled For November 6, 2025benzinga.com
Via Benzinga · November 6, 2025
AMN Healthcare Announces Third Quarter 2025 Results
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39
By AMN Healthcare Services Inc · Via GlobeNewswire · November 6, 2025
AMN Healthcare Services (AMN) Q3 Earnings Report Preview: What To Look For
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) will be reporting results this Thursday after market close. Here’s what to expect.
Via StockStory · November 4, 2025
3 Reasons AMN is Risky and 1 Stock to Buy Instead
AMN Healthcare Services currently trades at $20.73 per share and has shown little upside over the past six months, posting a middling return of 2.8%. The stock also fell short of the S&P 500’s 23.9% gain during that period.
Via StockStory · October 29, 2025
2 Unpopular Stocks That Deserve Some Love and 1 Facing Headwinds
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · October 28, 2025
Analyst Expectations For AMN Healthcare Services's Futurebenzinga.com
Via Benzinga · October 13, 2025
AMN Healthcare Services (AMN) Stock Trades Up, Here Is Why
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 3.2% in the afternoon session after Truist Securities reiterated its "Buy" rating and increased its price target on the company's stock. The firm's analyst, Tobey Sommer, lifted the target by 20% to $24.00 from a previous $20.00. This adjustment pointed to a positive outlook on the company's future performance. The move provided a notable point of optimism, especially when viewed against the wider analyst consensus which had previously set an average price target of $20.00 for the stock.
Via StockStory · October 13, 2025
Waller Sounds Alarm on 'Negative Job Growth,' Signaling Deeper Fed Cuts Ahead
Washington D.C. – October 10, 2025 – Federal Reserve Governor Christopher Waller delivered a stark warning today, Friday, October 10, 2025, sending ripples through financial markets with his assertion of "negative job growth" and a significantly stalling U.S. labor market. Speaking on CNBC's "Squawk Box," Waller’s remarks underscore a
Via MarketMinute · October 10, 2025
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory · October 10, 2025
AMN Healthcare to Hold Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025
DALLAS, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2025 financial results and fourth quarter 2025 outlook on Thursday, November 6, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.
By AMN Healthcare Services Inc · Via GlobeNewswire · October 8, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 2, 2025
U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025. This concerning assessment comes at a critical juncture for the economy, compounded by an ongoing federal government
Via MarketMinute · October 6, 2025
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series of White House initiatives and legislative actions, most notably the ongoing implementation of the Inflation Reduction Act (IRA) and the pursuit
Via MarketMinute · September 30, 2025
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a broader market optimism rippling through the healthcare sector. While AMN's direct stock drivers often stem from company-specific operational successes, today's surge
Via MarketMinute · September 30, 2025
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing agreement reached between the White House and a major pharmaceutical player, Pfizer (NYSE: PFE). This development has been widely interpreted by investors as
Via MarketMinute · September 30, 2025
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory · September 30, 2025
3 Small-Cap Stocks That Concern Us
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · September 25, 2025
AMN Healthcare Announces Pricing of Senior Notes Offering
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031. The 2031 Notes will bear an interest rate of 6.500% per annum and will be issued at 100.0% of their face value. The 2031 Notes will be guaranteed by the Company’s affiliates that guarantee the Company’s credit facilities.
By AMN Healthcare Services Inc · Via GlobeNewswire · September 22, 2025
AMN Healthcare Launches $400.0 Million Offering of Senior Notes
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031, subject to market and other conditions. The 2031 Notes will be guaranteed by the Company’s affiliates that guarantee the Company’s credit facilities.
By AMN Healthcare Services Inc · Via GlobeNewswire · September 22, 2025
Why AMN Healthcare Services (AMN) Shares Are Getting Obliterated Today
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) fell 6.2% in the afternoon session after Bank of America Securities lowered its price target on the stock from $20.00 to $18.00. 
Via StockStory · September 10, 2025
1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Via StockStory · September 8, 2025
3 Hyped Up Stocks with Open Questions
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Via StockStory · September 4, 2025